Sign In
Buy AXSM
$212.17
+1.13 (+0.535%)
At Close: Aug 04, 2026
Axsome Therapeutics Provides Update on the New Drug Application for AXS-05 for the Treatment of Major Depressive Disorder
06:00am, Monday, 23'rd Aug 2021
NEW YORK, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorder
Is the Options Market Predicting a Spike in Axsome (AXSM) Stock?
11:25am, Friday, 20'th Aug 2021
Investors need to pay close attention to Axsome (AXSM) stock based on the movements in the options market lately.
Could Biogen Acquire Axsome Therapeutics?
06:01am, Friday, 20'th Aug 2021
Here are three reasons why a buyout just might happen.
BioXcel: Recent Selloff Offers A Very Good Opportunity To Entry At A Discount Price
02:32pm, Wednesday, 18'th Aug 2021
BioXcel: Recent Selloff Offers A Very Good Opportunity To Entry At A Discount Price
3 Beaten Down Stocks that Could be Ready to Bounce
07:14am, Tuesday, 17'th Aug 2021
Photo credit sergeitokmakov @ Pixabay Trading against the trend can be a very difficult way to generate returns in the market, yet there usually comes a time when a stock in a downtrend simply runs ou
2 Beaten-Down Biotech Stocks: Are They Bargains Now?
06:31am, Tuesday, 17'th Aug 2021
These drugmakers delivered some upsetting news, but was it really so bad?
Los Angeles, California--(Newsfile Corp. - August 16, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ax
Axsome: Is The Pullback A Buying Opportunity?
08:00am, Sunday, 15'th Aug 2021
Axsome is down due to two adverse events. The first, rescinding of the BTD for AXS-12, is a non-event.
Why Shares of Axsome Therapeutics Are Down Friday
03:29pm, Friday, 13'th Aug 2021
The biotech stock has lost half of its value over the past week.
Los Angeles, California--(Newsfile Corp. - August 13, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ax
Los Angeles, California--(Newsfile Corp. - August 12, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ax
CORRECTING and REPLACING Scott+Scott Attorneys at Law LLP Announces Investigation into Axsome Therapeutics Inc. (AXSM)
11:39am, Wednesday, 11'th Aug 2021
NEW YORK--(BUSINESS WIRE)-- #AXSM--Scott+Scott Attorneys at Law LLP Announces Investigation into Axsome Therapeutics Inc. (AXSM)
Los Angeles, California--(Newsfile Corp. - August 11, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ax
NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Axsome Therapeutics, Inc. (“Axsome” or the �
Scott+Scott Attorneys at Law LLP Announces Investigation into Axsome Therapeutics Inc. (AXSM)
04:16pm, Tuesday, 10'th Aug 2021
NEW YORK--(BUSINESS WIRE)-- #AXSM--Scott+Scott Attorneys at Law LLP Announces Investigation into Axsome Therapeutics Inc. (AXSM)
